LRMR
Larimar Therapeutics, Inc.·Healthcare
4.85
4.715%(−0.24)
Market ClosedLast Updated: — ET
52W L: $1.7352W H: $6.42
LRMR NEWS
globenewswire.com
Mar 19
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
* Pro forma cash, cash equivalents, and marketable securities of $244.5 million reflects $136.9 million of cash, cash equivalents and marketable securities as of December 31, 2025 combined with the $107.6 million in net proceeds from the recently completed February 2026 public offering.
defenseworld.net
Mar 15
Investors Buy Large Volume of Larimar Therapeutics Call Options (NASDAQ:LRMR)
Larimar Therapeutics, Inc. (NASDAQ: LRMR - Get Free Report) was the target of some unusual options trading activity on Friday. Investors purchased 3,011 call options on the company. This represents an increase of approximately 250% compared to the average daily volume of 861 call options. Larimar Therapeutics Stock Down 3.8% Larimar Therapeutics stock opened at $4.59
investorplace.com
Mar 8
2 Breakout Stocks to Buy Immediately
Tom Yeung here with your Sunday Digest . In 2015, I visited the observatory at One World Trade Center – the newly opened viewing deck on the Western Hemisphere's tallest building.
zacks.com
Mar 6
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Larimar's stock jumps 55% in a month after the FDA grants breakthrough therapy status to its FA drug nomlabofusp and backs a potential accelerated path.
globenewswire.com
Mar 4
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
BALA CYNWYD, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company's management team will present and participate in 1x1 investor meetings at the following upcoming investor conferences taking place in Miami Beach, FL.
gurufocus.com
Mar 3
Market Today: Stocks Slide, Oil Majors Rally, Big Deals and FDA Setbacks
Guru Stock PicksKen Fisher has made the following transactions:Reduce in DEO by 23.8%Sold out in VSHAdd in AMKR by 204.55%New position in BROChuck Royce has mad
